SCHEMBL20852261

SCHEMBL20852261

CC(C)(O)CNC(=O)CCOCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 6/20 0.59
▸ TDP1 Q9NUW8 5/20 0.58
▸ F2 P00734 1/20 0.57
▸ PRSS1 P07477 1/20 0.57
▸ PRSS2 P07478 1/20 0.57
▸ PRSS3 P35030 1/20 0.57
▸ TPSAB1 Q15661 1/20 0.57
▸ PKM P14618 3/20 0.54
▸ HSP90AB1 P08238 1/20 0.52
▸ PLCD1 P51178 1/20 0.52
▸ CA12 O43570 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ IDE P14735 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21981271 0.95 F2 (0.63) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL19427225 0.90 F2 (0.61) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL19427224 0.90 F2 (0.61) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL27075284 0.89 TDP1 (0.64) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL25894853 0.88 PRSS1 (0.65) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL15258705 0.87 F2 (0.60) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL10689008 0.87 TDP1 (0.58) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL13041591 0.87 F2 (0.60) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL18905056 0.87 F2 (0.61) FOLH1TDP1F2PRSS1PRSS2
SCHEMBL17522651 0.87 F2 (0.61) FOLH1TDP1F2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10451632-B2 Cleavable probes for isotope targeted glycoproteomics and methods of using the same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-10-22 — — US disclosed
US-20190094238-A1 CLEAVABLE PROBES FOR ISOTOPE TARGETED GLYCOPROTEOMICS AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190094238-A1 CLEAVABLE PROBES FOR ISOTOPE TARGETED GLYCOPROTEOMICS AND METHODS OF USING THE SAME DNPEP, ANPEP, PTMS FOLH1 165/4885TDP1 3792/4885F2 1984/4885
US-10451632-B2 Cleavable probes for isotope targeted glycoproteomics and methods of using the same DNPEP, ANPEP, PTMS FOLH1 165/4885TDP1 3792/4885F2 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback